Your browser doesn't support javascript.
loading
Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HF.
Butt, Jawad H; Dewan, Pooja; DeFilippis, Ersilia M; Biering-Sørensen, Tor; Docherty, Kieran F; Jhund, Pardeep S; Kosiborod, Mikhail N; Martinez, Felipe A; Bengtsson, Olof; Johansen, Niklas Dyrby; Langkilde, Anna Maria; Sjöstrand, Mikaela; Vaduganathan, Muthiah; Solomon, Scott D; Sabatine, Marc S; Køber, Lars; Fiuzat, Mona; McMurray, John J V.
Afiliación
  • Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Dewan P; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • DeFilippis EM; Columbia University Irving Medical Center, New York, New York, USA.
  • Biering-Sørensen T; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Hellerup, Denmark.
  • Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, Missouri, USA; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina.
  • Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Johansen ND; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Hellerup, Denmark.
  • Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Vaduganathan M; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Sabatine MS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Køber L; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Fiuzat M; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
JACC Heart Fail ; 10(8): 543-555, 2022 08.
Article en En | MEDLINE | ID: mdl-35902157
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Disfunción Ventricular Izquierda / Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Guideline / Qualitative_research Idioma: En Revista: JACC Heart Fail Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Disfunción Ventricular Izquierda / Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Guideline / Qualitative_research Idioma: En Revista: JACC Heart Fail Año: 2022 Tipo del documento: Article